Targeted ROS releasing PEG-Fibrin composite adhesive-hydrogel to control matrix modulation as a wound healing and tissue engineering support

NIH RePORTER · NIH · R15 · $400,343 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY This proposal addresses several existing challenges in developing better control systems for therapeutic tissue engineering including: 1) minimizing infection associated with delivered biomaterials/devices; 2) creating in-situ curable material with a suitable environment for local cell migration, stable cell delivery and promotion of injury repair; 3) establishing a stable adhesive interface between a tissue engineered construct (hydrogel) and injured tissues; 4) targeting spatial and temporal release of multifunctional dose dependent reactive oxygen species (ROS). The ROS releasing composite adhesive-hydrogels and focused ultrasound (FUS) delivery system being developed in this proposal addresses these challenges. The primary innovative component is the possible use of FUS to spatially and temporally target ROS release as a regenerative tissue support that not only aids in stabilizing the matrix metabolic activity of the regenerative site but also provides secondary support through its innate antimicrobial character. The main objectives of this proposal are: 1) create a library of composite hydrogel formulations with controlled ROS release profiles as well as physical and adhesive properties; 2) build a custom FUS therapy system and characterize its ability modulate formulations in real-time to target wound healing and prevent infection in vitro; 3) verify candidate formulations promote wound healing in an Achilles tendon defect model.

Key facts

NIH application ID
9965158
Project number
1R15GM137298-01
Recipient
MICHIGAN TECHNOLOGICAL UNIVERSITY
Principal Investigator
Smitha Rao Hatti
Activity code
R15
Funding institute
NIH
Fiscal year
2020
Award amount
$400,343
Award type
1
Project period
2020-05-01 → 2024-04-30